These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19139007)

  • 1. Dose-dependent inhibition of tobacco smoke carcinogen-induced lung tumorigenesis in A/J mice by indole-3-carbinol.
    Kassie F; Matise I; Negia M; Upadhyaya P; Hecht SS
    Cancer Prev Res (Phila); 2008 Dec; 1(7):568-76. PubMed ID: 19139007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of lung lesions in Wistar rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its inhibition by aspirin and phenethyl isothiocyanate.
    Ye B; Zhang YX; Yang F; Chen HL; Xia D; Liu MQ; Lai BT
    BMC Cancer; 2007 May; 7():90. PubMed ID: 17535415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of tobacco smoke-induced lung tumors by inhalation of an epigallocatechin gallate (EGCG) aerosol: a pilot study.
    Witschi H; Espiritu I; Ly M; Uyeminami D; Morin D; Raabe OG
    Inhal Toxicol; 2004; 16(11-12):763-70. PubMed ID: 16036746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydromethysticin (DHM) Blocks Tobacco Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-Induced O
    Narayanapillai SC; Lin SH; Leitzman P; Upadhyaya P; Baglole CJ; Xing C
    Chem Res Toxicol; 2016 Nov; 29(11):1828-1834. PubMed ID: 27728767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexposure to Inhaled Aldehydes or Carbon Dioxide Enhances the Carcinogenic Properties of the Tobacco-Specific Nitrosamine 4-Methylnitrosamino-1-(3-pyridyl)-1-butanone in the A/J Mouse Lung.
    Peterson LA; Oram MK; Flavin M; Seabloom D; Smith WE; O'Sullivan MG; Vevang KR; Upadhyaya P; Stornetta A; Floeder AC; Ho YY; Zhang L; Hecht SS; Balbo S; Wiedmann TS
    Chem Res Toxicol; 2021 Mar; 34(3):723-732. PubMed ID: 33629582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of tobacco-smoke lung carcinogenesis in mice after cessation of smoke exposure.
    Witschi H; Uyeminami D; Moran D; Espiritu I
    Carcinogenesis; 2000 May; 21(5):977-82. PubMed ID: 10783321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-inhibitory effects of the chemopreventive agent indole-3-carbinol are increased in combination with the polyamine putrescine in the SW480 colon tumour cell line.
    Hudson EA; Howells LM; Gallacher-Horley B; Fox LH; Gescher A; Manson MM
    BMC Cancer; 2003 Jan; 3():2. PubMed ID: 12525265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of the relative mutagenicity of five chemical constituents of tobacco smoke in the mouse lymphoma assay.
    Guo X; Heflich RH; Dial SL; Richter PA; Moore MM; Mei N
    Mutagenesis; 2016 May; 31(3):287-96. PubMed ID: 26001754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of tobacco ingredients on smoke chemistry. Part I: Flavourings and additives.
    Baker RR; Pereira da Silva JR; Smith G
    Food Chem Toxicol; 2004; 42 Suppl():S3-37. PubMed ID: 15072836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of dietary myoinositol on lung tumor development in tobacco smoke-exposed mice.
    Witschi H; Espiritu I; Ly M; Uyeminami D
    Inhal Toxicol; 2004 Apr; 16(4):195-201. PubMed ID: 15204766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012.
    Wei B; Blount BC; Xia B; Wang L
    J Expo Sci Environ Epidemiol; 2016; 26(3):249-56. PubMed ID: 25564369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates.
    Rubin H
    Carcinogenesis; 2001 Dec; 22(12):1903-30. PubMed ID: 11751421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model.
    Megaraj V; Zhou X; Xie F; Liu Z; Yang W; Ding X
    Carcinogenesis; 2014 Jan; 35(1):131-7. PubMed ID: 23917075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial.
    Kim P; Sanchez AM; Penke TJR; Tuson HH; Kime JC; McKee RW; Slone WL; Conley NR; McMillan LJ; Prybol CJ; Garofolo PM
    Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers.
    Stepanov I; Upadhyaya P; Carmella SG; Feuer R; Jensen J; Hatsukami DK; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1764-73. PubMed ID: 18628430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells.
    West KA; Brognard J; Clark AS; Linnoila IR; Yang X; Swain SM; Harris C; Belinsky S; Dennis PA
    J Clin Invest; 2003 Jan; 111(1):81-90. PubMed ID: 12511591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and subacute effects of tobacco alkaloids, tobacco-specific nitrosamines and phenethyl isothiocyanate on N'-nitrosonornicotine metabolism in rats.
    Tyroller S; Zwickenpflug W; Thalheim C; Richter E
    Toxicology; 2005 Nov; 215(3):245-53. PubMed ID: 16118032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) mutagenicity using in vitro and in vivo Pig-a assays.
    Mittelstaedt RA; Dobrovolsky VN; Revollo JR; Pearce MG; Wang Y; Dad A; McKinzie PB; Rosenfeldt H; Yucesoy B; Yeager R; Hu SC; Tang Y; Min S; Kang HK; Yang DJ; Basavarajappa M; Heflich RH
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Jan; 837():65-72. PubMed ID: 30595212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tobacco smoke, nicotine, and cotinine on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
    Brown B; Avalos J; Lee C; Doolittle D
    Mutat Res; 2001 Jul; 494(1-2):21-9. PubMed ID: 11423342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.